ANX-1502

N/A

Report date: 2022/11/20 17:06:55
NME

Base Information

Drug NameANX-1502
Drug Alias NameANX-1502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement C1 inhibitors
TargetsComplement C1
Therapy Area/IndicationsAutoimmune Diseases of the Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnnexon Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnnexon Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases of the Nervous System
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A